Birdwatch Note Rating
2023-11-29 22:21:37 UTC - HELPFUL
Rated by Participant: B7E8CCCDBB26F04774FA1531E53886976DF726A753F826BCF32FE4F2E27553D3
Participant Details
Original Note:
The Food and Drug Administration considers aesthetic breast augmentation for patients less than 18 years of age to be an off-label use. The FDA has not approved breast augmentation in patients younger than 18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411597/#:~:text=The%20Food%20and%20Drug%20Administration,risks%20associated%20with%20breast%20implants.
All Note Details